MicroRNA in prostate, bladder, and kidney cancer: A systematic review

European Urology

Volumn 59, Issue 5, 2011, Pages 671-681

  Catto, James W F ^a,j   Alcaraz, Antonio ^b   Bjartell, Anders S ^c   De Vere White, Ralph ^d   Evans, Christopher P ^d   Fussel, Susanne ^e   Hamdy, Freddie C ^f   Kallioniemi, Olli ^g   Mengual, Lourdes ^b   Schlomm, Thorsten ^h   Visakorpi, Tapio ⁱ  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF BARCELONA   (Spain)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF HELSINKI   (Finland)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ UNIVERSITY OF TAMPERE   (Finland)

^j UNIVERSITY OF SHEFFIELD   (United Kingdom)

more..

Author keywords

Bladder; Cancer; Gene regulation; Kidney; MicroRNA; Prostate

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA; MIR 16; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLADDER CANCER; CELL PROLIFERATION; HUMAN; KIDNEY CANCER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SYNTHESIS; SYSTEMATIC REVIEW;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; KIDNEY NEOPLASMS; MALE; MICRORNAS; PROGNOSIS; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 79953249325     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.01.044     Document Type: Review

References (96)

1. C.M. Croce Causes and consequences of microRNA dysregulation in cancer Nat Rev Genet 10 2009 704 714
2. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
3. G.A. Calin, C.G. Liu, and C. Sevignani MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias Proc Natl Acad Sci U S A 101 2004 11755 11760 (Pubitemid 39095368)
4. H. Guo, N.T. Ingolia, J.S. Weissman, and D.P. Bartel Mammalian microRNAs predominantly act to decrease target mRNA levels Nature 466 2010 835 840
5. L. Poliseno, L. Salmena, J. Zhang, B. Carver, W.J. Haveman, and P.P. Pandolfi A coding-independent function of gene and pseudogene mRNAs regulates tumour biology Nature 465 2010 1033 1038
6. M. Yamakuchi, M. Ferlito, and C.J. Lowenstein miR-34a repression of SIRT1 regulates apoptosis Proc Natl Acad Sci U S A 105 2008 13421 13426
7. P. Lamy, C.L. Andersen, L. Dyrskjot, N. Torring, T. Orntoft, and C. Wiuf Are microRNAs located in genomic regions associated with cancer? Br J Cancer 95 2006 1415 1418 (Pubitemid 44760095)
8. G.A. Calin, M. Ferracin, and A. Cimmino A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia N Engl J Med 353 2005 1793 1801 (Pubitemid 41549891)
9. H. Choudhry, and J.W. Catto Epigenetic regulation of microRNA expression in cancer Methods Mol Biol 676 2010 165 184
10. Dudziec E, Miah S, Choudhury HMZ, et al. Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer. Clin Cancer Res. In press. doi:10.1158/1078-0432.CCR-10-2017.
11. E.D. Wiklund, J.B. Bramsen, and T. Hulf Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer Int J Cancer 128 2011 1327 1334
12. H.E. Rauhala, S.E. Jalava, and J. Isotalo miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer Int J Cancer 127 2010 1363 1372
13. S. Varambally, Q. Cao, and R.S. Mani Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer Science 322 2008 1695 1699
14. L. He, J.M. Thomson, and M.T. Hemann A microRNA polycistron as a potential human oncogene Nature 435 2005 828 833 (Pubitemid 40839734)
15. A. Rodriguez, S. Griffiths-Jones, J.L. Ashurst, and A. Bradley Identification of mammalian microRNA host genes and transcription units Genome Res 14 2004 1902 1910 (Pubitemid 39386503)
16. S. Ambs, R.L. Prueitt, and M. Yi Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer Cancer Res 68 2008 6162 6170
17. R.E. Lanford, E.S. Hildebrandt-Eriksen, and A. Petri Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327 2010 198 201
18. Y. Chen, X. Zhu, X. Zhang, B. Liu, and L. Huang Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy Mol Ther 18 2010 1650 1656
19. C.Y. Lee, P.S. Rennie, and W.W. Jia MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells Clin Cancer Res 15 2009 5126 5135
20. E. Ylosmaki, T. Hakkarainen, A. Hemminki, T. Visakorpi, R. Andino, and K. Saksela Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA J Virol 82 2008 11009 11015
21. K.P. Porkka, M.J. Pfeiffer, K.K. Waltering, R.L. Vessella, T.L. Tammela, and T. Visakorpi MicroRNA expression profiling in prostate cancer Cancer Res 67 2007 6130 6135 (Pubitemid 47037493)
22. Y. Sylvestre, V. De Guire, and E. Querido An E2F/miR-20a autoregulatory feedback loop J Biol Chem 282 2007 2135 2143 (Pubitemid 47076740)
23. P. Gandellini, M. Folini, and N. Longoni miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon Cancer Res 69 2009 2287 2295
24. T. Papagiannakopoulos, A. Shapiro, and K.S. Kosik MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells Cancer Res 68 2008 8164 8172
25. Z. Lu, M. Liu, and V. Stribinskis MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene Oncogene 27 2008 4373 4379 (Pubitemid 352010003)
26. C.H. Yang, J. Yue, M. Fan, and L.M. Pfeffer IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis Cancer Res 70 2010 8108 8116
27. K. Kojima, Y. Fujita, Y. Nozawa, T. Deguchi, and M. Ito MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms Prostate 70 2010 1501 1512
28. Z. Hagman, O. Larne, and A. Edsjo miR-34c is down regulated in prostate cancer and exerts tumor suppressive functions Int J Cancer 127 2010 2768 2776
29. S. Galardi, N. Mercatelli, and E. Giorda miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1 J Biol Chem 282 2007 23716 23724 (Pubitemid 47311902)
30. D. Bonci, V. Coppola, and M. Musumeci The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities Nat Med 14 2008 1271 1277
31. S. Josson, S.Y. Sung, K. Lao, L.W. Chung, and P.A. Johnstone Radiation modulation of microRNA in prostate cancer cell lines Prostate 68 2008 1599 1606
32. T. Li, D. Li, J. Sha, P. Sun, and Y. Huang MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells Biochem Biophys Res Commun 383 2009 280 285
33. X.B. Shi, L. Xue, and J. Yang An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells Proc Natl Acad Sci U S A 104 2007 19983 19988
34. X.B. Shi, L. Xue, A.H. Ma, C.G. Tepper, H.J. Kung, and R.W. White miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes Prostate 71 2011 538 549
35. J. Ribas, X. Ni, and M. Haffner miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth Cancer Res 69 2009 7165 7169
36. S.L. Lin, A. Chiang, D. Chang, and S.Y. Ying Loss of mir-146a function in hormone-refractory prostate cancer RNA 14 2008 417 424 (Pubitemid 351397806)
37. K.K. Waltering, K.P. Porkka, and S.E. Jalava Androgen regulation of micro-RNAs in prostate cancer Prostate 71 2011 604 614
38. P.S. Mitchell, R.K. Parkin, and E.M. Kroh Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518
39. T. Sun, Q. Wang, S. Balk, M. Brown, G.S. Lee, and P. Kantoff The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines Cancer Res 69 2009 3356 3363
40. S. Minner, B. Jessen, and L. Stiedenroth Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer Clin Cancer Res 16 2010 1553 1560
41. M.R. Epis, K.M. Giles, A. Barker, T.S. Kendrick, and P.J. Leedman miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer J Biol Chem 284 2009 24696 24704
42. L. Wang, H. Tang, and V. Thayanithy Gene networks and microRNAs implicated in aggressive prostate cancer Cancer Res 69 2009 9490 9497
43. J.A. Weber, D.H. Baxter, and S. Zhang The microRNA spectrum in 12 body fluids Clin Chem 56 2010 1733 1741
44. J.C. Brase, M. Johannes, and T. Schlomm Circulating miRNAs are correlated with tumor progression in prostate cancer Int J Cancer 128 2011 608 616
45. M.J. Lodes, M. Caraballo, D. Suciu, S. Munro, A. Kumar, and B. Anderson Detection of cancer with serum miRNAs on an oligonucleotide microarray PLoS One 4 2009 e6229
46. H.L. Zhang, L.F. Yang, and Y. Zhu Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy Prostate 71 2011 326 331
47. F. Moltzahn, A.B. Olshen, and L. Baehner Microfluidic based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in sera of prostate cancer patients Cancer Res 71 2011 550
48. Saini S, Majid S, Yamamura S, et al. Regulatory role of miR-203 in prostate cancer progression and metastasis. Clin Cancer Res. In press. doi:10.1158/1078-0432.CCR-10-2619.
49. F. Gottardo, C.G. Liu, and M. Ferracin Micro-RNA profiling in kidney and bladder cancers Urol Oncol 25 2007 387 392 (Pubitemid 47362758)
50. L. Dyrskjot, M.S. Ostenfeld, and J.B. Bramsen Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro Cancer Res 69 2009 4851 4860
51. J.W. Catto, S. Miah, and H.C. Owen Distinct microRNA alterations characterize high- and low-grade bladder cancer Cancer Res 69 2009 8472 8481
52. D.R. Yates, I. Rehman, and M.F. Abbod Promoter hypermethylation identifies progression risk in bladder cancer Clin Cancer Res 13 2007 2046 2053 (Pubitemid 46649871)
53. J.W.F. Catto, M.F. Abbod, and P.J. Wild The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression Eur Urol 57 2010 398 406
54. S. Veerla, D. Lindgren, and A. Kvist MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31 Int J Cancer 124 2009 2236 2242
55. L.A. Neely, K.M. Rieger-Christ, and B.S. Neto A microRNA expression ratio defining the invasive phenotype in bladder tumors Urol Oncol 28 2010 39 48
56. L. Adam, M. Zhong, and W. Choi miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy Clin Cancer Res 15 2009 5060 5072
57. P.A. Kenney, M.F. Wszolek, and K.M. Rieger-Christ Novel ZEB1 expression in bladder tumorigenesis BJU Int 107 2011 656 663
58. U. Burk, J. Schubert, and U. Wellner A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells EMBO Rep 9 2008 582 589 (Pubitemid 351772923)
59. M. Hanke, K. Hoefig, and H. Merz A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer Urol Oncol 28 2010 655 661
60. K.K. Dutta, Y. Zhong, and Y.T. Liu Association of microRNA-34a overexpression with proliferation is cell type-dependent Cancer Sci 98 2007 1845 1852 (Pubitemid 350002188)
61. D. Juan, G. Alexe, and T. Antes Identification of a microRNA panel for clear-cell kidney cancer Urology 75 2010 835 841
62. Y. Huang, Y. Dai, and J. Yang Microarray analysis of microRNA expression in renal clear cell carcinoma Eur J Surg Oncol 35 2009 1119 1123
63. C. Nakada, K. Matsuura, and Y. Tsukamoto Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c J Pathol 216 2008 418 427
64. D. Petillo, E.J. Kort, J. Anema, K.A. Furge, X.J. Yang, and B.T. Teh MicroRNA profiling of human kidney cancer subtypes Int J Oncol 35 2009 109 114
65. L. Weng, X. Wu, and H. Gao MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens J Pathol 222 2010 41 51
66. T. Wurdinger, B.A. Tannous, and O. Saydam miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells Cancer Cell 14 2008 382 393
67. S. Sinha, S. Dutta, K. Datta, A.K. Ghosh, and D. Mukhopadhyay Von Hippel-Lindau gene product modulates TIS11B expression in renal cell carcinoma: impact on vascular endothelial growth factor expression in hypoxia J Biol Chem 284 2009 32610 32618
68. C.S. Neal, M.Z. Michael, L.H. Rawlings, M.B. Van der Hoek, and J.M. Gleadle The VHL-dependent regulation of microRNAs in renal cancer BMC Med 8 2010 64
69. W. Liu, O. Zabirnyk, and H. Wang miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer Oncogene 29 2010 4914 4924
70. E.J. Kort, L. Farber, and M. Tretiakova The E2F3-Oncomir-1 axis is activated in Wilms' tumor Cancer Res 68 2008 4034 4038
71. T.F. Chow, M. Mankaruos, and A. Scorilas The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma J Urol 183 2010 743 751
72. A. Veronese, L. Lupini, and J. Consiglio Oncogenic role of miR-483-3p at the IGF2/483 locus Cancer Res 70 2010 3140 3149
73. A.G. Bader, D. Brown, and M. Winkler The promise of microRNA replacement therapy Cancer Res 70 2010 7027 7030
74. F. Takeshita, L. Patrawala, and M. Osaki Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes Mol Ther 18 2010 181 187
75. M.S. Zaman, Y. Chen, and G. Deng The functional significance of microRNA-145 in prostate cancer Br J Cancer 103 2010 256 264
76. V. Brower RNA interference advances to early-stage clinical trials J Natl Cancer Inst 102 2010 1459 1461
77. W. Qin, Y. Shi, and B. Zhao miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells PLoS One 5 2010 e9429
78. B. Li, X.B. Shi, and D. Nori Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells Prostate 71 2011 567 574
79. T. Murata, K. Takayama, and S. Katayama miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression Prostate Cancer Prostatic Dis 13 2010 356 361
80. K.M. Giles, A. Barker, P.M. Zhang, M.R. Epis, and P.J. Leedman MicroRNA regulation of growth factor receptor signaling in human cancer cells Methods Mol Biol 676 2010 147 163
81. W.X. Wang, N. Kyprianou, X. Wang, and P.T. Nelson Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group Cancer Res 70 2010 9137 9142
82. J. Szczyrba, E. Loprich, and S. Wach The microRNA profile of prostate carcinoma obtained by deep sequencing Mol Cancer Res 8 2010 529 538
83. C. Clape, V. Fritz, and C. Henriquet miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice PLoS One 4 2009 e7542
84. Y. Fujita, K. Kojima, and R. Ohhashi MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression J Biol Chem 285 2010 19076 19084
85. S. Majid, A.A. Dar, and S. Saini MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer Cancer 116 2010 5637 5649
86. E.J. Noonan, R.F. Place, and D. Pookot miR-449a targets HDAC-1 and induces growth arrest in prostate cancer Oncogene 28 2009 1714 1724
87. S. Majid, A.A. Dar, and S. Saini Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer Cancer Res 70 2010 2809 2818
88. Q. Dong, P. Meng, and T. Wang MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2 PLoS One 5 2010 e10147
89. Q. Lu, C. Lu, G.P. Zhou, W. Zhang, H. Xiao, and X.R. Wang MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL Urol Oncol 28 2010 635 641
90. Chiyomaru T, Enokida H, Kawakami K, et al. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol. In press. doi:10.1016/j.urolonc.2010.05.008.
91. Y. Cao, S.L. Yu, Y. Wang, G.Y. Guo, and Q. Ding An RH. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24 Tumour Biol 32 2011 179 188
92. T. Ichimi, H. Enokida, and Y. Okuno Identification of novel microRNA targets based on microRNA signatures in bladder cancer Int J Cancer 125 2009 345 352
93. D. Lodygin, V. Tarasov, and A. Epanchintsev Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer Cell Cycle 7 2008 2591 2600
94. J.M. Friedman, G. Liang, and C.C. Liu The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2 Cancer Res 69 2009 2623 2629
95. L. Huang, J. Luo, and Q. Cai MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3 Int J Cancer 128 2011 1758 1769
96. M.S. Ostenfeld, J.B. Bramsen, and P. Lamy miR-145 induces caspase-dependent and independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors Oncogene 29 2010 1073 1084